Mitochondrial DNA Sensing Reshapes the Tumor Immune Microenvironment via Cooperative cGAS-STING Activation and Ferroptosis

Mitochondrial DNA Sensing Reshapes the Tumor Immune Microenvironment via Cooperative cGAS-STING Activation and Ferroptosis

Authors

DOI:

https://doi.org/10.63808/ghc.v2i1.524

Keywords:

Mitochondrial DNA, cGAS-STING signaling pathway, Ferroptosis, Tumor immune microenvironment, Immunotherapy

Abstract

Abnormal release of mitochondrial DNA (mtDNA) and innate immune sensing play key roles in tumor immune regulation, but how they work together with ferroptosis is still unclear. This study aims to clarify the molecular mechanism of how mtDNA reshapes the tumor immune microenvironment in coordination with ferroptosis through activating the cGAS-STING signaling pathway, as well as its anti-tumor potential. By creating tumor cell mitochondrial stress models and using CRISPR-Cas9 gene knockout, lipid peroxidation detection, single-cell transcriptome analysis, and mouse syngeneic tumor models, we systematically assessed how mtDNA release affects the cGAS-STING pathway and ferroptosis. The results showed that mitochondrial stress-induced cytoplasmic mtDNA release significantly activates the cGAS-STING pathway, upregulates type I interferons and chemokines like CXCL10, and promotes lipid peroxidation and ferroptosis by suppressing the xCT/GPX4 antioxidant axis. Ferroptotic tumor cells further release damage-associated molecules like HMGB1 and ATP, enhancing dendritic cell maturation and CD8⁺ T cell tumor infiltration, forming a positive feedback loop of immune activation. In mouse melanoma models, combining mtDNA release with ferroptosis significantly inhibited tumor growth and extended survival, showing better results than either intervention alone. This study reveals a new mechanism where mtDNA sensing collaborates with ferroptosis via the cGAS-STING pathway to reshape the tumor immune microenvironment, providing a theoretical basis and potential targets for developing anti-tumor immunotherapies that jointly regulate innate immunity and ferroptosis.

References

[1] Ablasser, A., Goldeck, M., Cavlar, T., Deimling, T., Witte, G., Röhl, I., et al. (2013). cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING. Nature, 498(7454), 380-384. https://doi.org/10.1038/nature12306

[2] Ahn, J., Xia, T., Konno, H., Konno, K., Ruiz, P., & Barber, G. N. (2014). Inflammation-driven carcinogenesis is mediated through STING. Nat Commun, 5, 5166. https://doi.org/10.1038/ncomms6166

[3] Chen, Q., Sun, L., & Chen, Z. J. (2016). Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nat Immunol, 17(10), 1142-9. https://doi.org/10.1038/ni.3558

[4] Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021). Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol, 18(5), 280-296. https://doi.org/10.1038/s41571-020-00462-0

[5] Deng, L., Liang, H., Xu, M., Yang, X., Burnette, B., Arina, A., et al. (2014). STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity, 41(5), 43-852. https://doi.org/10.1016/j.immuni.2014.10.019

[6] Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., et al. (2012). Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 149(5), 1060-1072. https://doi.org/10.1016/j.cell.2012.03.042

[7] Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., et al. (2018). Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018. Cell Death Differ, 25(3), 486-541. https://doi.org/10.1038/s41418-017-0012-4

[8] Hopfner, K. P., & Hornung, V. (2020). Molecular mechanisms and cellular functions of cGAS–STING signalling. Nat Rev Mol Cell Biol, 21(9), 501-521. https://doi.org/10.1038/s41580-020-0244-x

[9] Jia, M., Qin, D., Zhao, C., Chai, L., Yu, Z., Wang, W., et al. (2020). Redox homeostasis maintained by GPX4 facilitates STING activation. Nat Immunol, 21(7), 727-735. https://doi.org/10.1038/s41590-020-0699-0

[10] Jiang, X., Stockwell, B. R., & Conrad, M. (2021). Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol, 22(4), 266-282. https://doi.org/10.1038/s41580-020-00324-8

[11] Kwon, J., & Bakhoum, S. F. (2020). The cytosolic DNA-sensing cGAS-STING pathway in cancer. Cancer Discov, 10(1), 26-39. https://doi.org/10.1158/2159-8290.CD-19-0761

[12] Lang, X., Green, M. D., Wang, W., Yu, J., Choi, J. E., Jiang, L., et al. (2019). Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov, 9(12), 1673-1685. https://doi.org/10.1158/2159-8290.CD-19-0338

[13] Li, C., Zhang, Y., Liu, J., Kang, R., Klionsky, D. J., & Tang, D. (2021). Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death. Autophagy, 17(4), 948–960. https://doi.org/10.1080/15548627.2020.1739447

[14] Li, C., Zhao, W., Geng, D., Jin, Y., & Guan, W. (2025). Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer. J Exp Clin Cancer Res, 44(1), 249. https://doi.org/10.1186/s13046-025-03520-6

[15] Liu G. (2026). Tumor microenvironment: composition, dynamic evolution, and its significance in cancer treatment. Journal of Cancer Insights, 1(1), 6. https://doi.org/10.66128/JCI202601.1

[16] Liu, G., Wang, J., & Zhu, J. (2026). Explainable spatial AI analyzes tumor-immune interactions to predict immunotherapy outcomes and identify new targets. Intelligent & Human Futures, 2(3), 510. https://doi.org/10.63808/ihf.v2i3.510

[17] Riley, J. S., & Tait, S. W. (2020). Mitochondrial DNA in inflammation and immunity. EMBO Rep, 21(4), e49799. https://doi.org/10.15252/embr.201949799

[18] Sen, T., Rodriguez, B. L., Chen, L., Corte, C. M. D., Morikawa, N., Fujimoto, J., et al. (2019). Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer. Cancer Discov, 9(5), 646-661. https://doi.org/10.1158/2159-8290.CD-18-1020

[19] Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., et al. (2017). Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell, 171(2), 273-285. https://doi.org/10.1016/j.cell.2017.09.021

[20] Tigano, M., Vargas, D. C., Tremblay-Belzile, S., Fu, Y., & Sfeir, A. (2021). Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance. Nature, 591(7850), 477-481. https://doi.org/10.1038/s41586-021-03269-w

[21] Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., et al. (2019). CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature, 569(7755), 270-274. https://doi.org/10.1038/s41586-019-1170-y

[22] West, A. P., & Shadel, G. S. (2017). Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol, 17(6), 363-375. https://doi.org/10.1038/nri.2017.21

[23] West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., et al. (2015). Mitochondrial DNA stress primes the antiviral innate immune response. Nature, 520(7548), 553-557. https://doi.org/10.1038/nature14156

[24] Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., et al. (2014). Regulation of ferroptotic cancer cell death by GPX4. Cell, 156(1-2), 317-331. https://doi.org/10.1016/j.cell.2013.12.010

[25] Yum, S., Li, M., Fang, Y., & Chen, Z. J. (2021). TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections. Proc Natl Acad Sci U S A, 118(14), e2100225118. https://doi.org/10.1073/pnas.2100225118

[26] Zhu, Q., Man, S. M., Gurung, P., Liu, Z., Vogel, P., Lamkanfi, M., & Kanneganti, T. D. (2014). Cutting edge: STING mediates protection against colorectal tumorigenesis by governing the magnitude of intestinal inflammation. J Immunol, 193(10), 4779-82. https://doi.org/10.4049/jimmunol.1402051

Downloads

Published

2026-09-11
Loading...